Prevalence and mechanisms of macrolide resistance in clinical isolates of group A streptococci from Ontario, Canada

Antimicrob Agents Chemother. 1999 Sep;43(9):2144-7. doi: 10.1128/AAC.43.9.2144.

Abstract

A total of 3,205 group A streptoccal isolates were collected in 1997 through a private laboratory which serves community physicians in southern Ontario and which represents a population base of 6 million people. Nonsusceptibility to erythromycin was detected for 67 (2.1%) isolates both by disk diffusion and by broth microdilution. Of these, 47 (70%) were susceptible to clindamycin and were found by PCR to possess the mef gene. Of the other 20 strains, 18 and 2 showed inducible and constitutive resistance, respectively, to clindamycin. Nineteen of these strains were shown by PCR to possess the ermTR gene, and a single constitutively resistant strain harbored an ermB gene. Sixteen (24%) erythromycin-resistant strains were also resistant to tetracycline. All were susceptible to penicillin and chloramphenicol.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Drug Resistance, Microbial / genetics
  • Electrophoresis, Gel, Pulsed-Field
  • Erythromycin / pharmacology*
  • Genotype
  • Humans
  • Microbial Sensitivity Tests
  • Ontario
  • Phenotype
  • Prevalence
  • Streptococcus pyogenes / classification
  • Streptococcus pyogenes / drug effects*
  • Streptococcus pyogenes / genetics*
  • Streptococcus pyogenes / isolation & purification

Substances

  • Anti-Bacterial Agents
  • Erythromycin